2024-05-182024-05-1813754https://scholars.lib.ntu.edu.tw/handle/123456789/716788Dr. Huang has been the chief investigator of two clinical trials in Taiwan: a nationwide randomized trial of breast cancer screening using ultrasound and mammography for women aged 40–49; and a multi-center trial of tailored neoadjuvant chemotherapy for breast cancer.||A chief investigator of a global randomized trial of active immunotherapy in metastatic breast cancer and acts as a Steering Committee member in three global trials investigating two anti-Her-2 target therapies: afatinib in metastatic setting and T-DM1 in adjuvant and neoadjuvant setting.Breast SurgeryBreast UltrasoundBreast Cancer ScreeningSurgical OncologyMolecular EpidemiologyClinical TrialBreast SurgeryBreast UltrasoundBreast Cancer ScreeningSurgical OncologyMolecular EpidemiologyClinical Trial